Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a phone app ease endometriosis pain? new trial tests digital therapy

NCT ID NCT07175857

Symptom relief Sponsor: Lyv Healthcare Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a smartphone app called Lyv Endo, designed to help women with endometriosis manage their symptoms. The app gives personalized advice based on each woman's symptoms. The trial will track quality of life and symptom changes in 400 women over time. It aims to see if using the app alongside regular medical care can make a real difference.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Lyv Endo app (a digital therapeutic device that provides personalized content based on symptoms)
What this could lead to
If it works, this app could offer a new, accessible way for women with endometriosis to better manage their symptoms and improve daily life.
What could go wrong
This is a non-randomized study without a placebo control, so results may be less reliable. The app is a complement, not a cure, and benefits may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 400 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2025

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Women ≥18 years old * with confirmed endometriosis diagnosis * symptomatic patients (NRS ≥ 4 on one or more symptoms) * French-speaking * Owning a smartphone with internet/data, * covered by French social security Exclusion Criteria: * Planned surgery during the study or surgery in the past 8 weeks * Fertility hormone treatment during study * Previous use of full Lyv Endo app or pilot program * Pregnant or breastfeeding * Under legal protection (guardianship, etc.) * Cognitive or psychiatric conditions compromising consent * Judged non-autonomous by investigator * Participation in another interventional study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Endometriosis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

endometriosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Endometriosis

Contacts and locations

Locations

  • CHU CAEN

    Caen, France, 14000, France

  • CHU Rennes

    Rennes, France, 35000, France

  • Centre Hospitalier Le Mans

    Le Mans, 72000, France

  • Centre Hospitalier de Versailles

    Le Chesnay, 78157, France

  • Clinique Tivoli Ducos

    Bordeaux, 33000, France

  • Hôpital Le Blois

    Lille, 59000, France

  • Hôpital Paris Saint-Joseph

    Paris, 75014, France

  • Hôpital Privé de Provence

    Aix-en-Provence, France, 13080, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.